Viral hepatitis is a disease of major significance in terms of morbidity and mortality. In most cases, hepatitis is a disease that is not discriminating and selective to limited geographical groups or social and socioeconomic factors. So it is necessary that the physician, the clinician and other health care professionals know how to diagnose and monitor viral hepatitis. One hundred and fifty million people are chronically infected with the virus of Hepatitis C, 2 billion people (estimated) worldwide have been infected with the Hepatitis B virus and 1.4 million estimated cases of Hepatitis A occur annually.
Laboratory tests are therefore essential to provide clinicians with the tools to improve patient management. DiaSorin offers diagnostic solutions, with a wide range of instruments and highly sensitive and specific assays, on the ELISA format (Hepatitis A, B, and C) and for the LIAISON® systems (Hepatitis A).